Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survival

Por Fromigue, O, Kheddoumi, N, Body, J-J
Publicado em 2003

Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy.

Por Body, J. J., Dumon, J. C., Gineyts, E., Delmas, P. D.
Publicado em 1997

Gorham–Stout disease of the proximal fibula treated with radiotherapy and zoledronic acid

Por Yerganyan, V.V., Body, J.J., De Saint Aubain, N., Gebhart, M.
Publicado no J Bone Oncol (2015)

Rh-D isoimmunization.

Por Body, J. J., Strickler, R. C., McClure, P. D., Freedman, M. H.
Publicado em 1972

Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells

Por Journe, F, Chaboteaux, C, Dumon, J-C, Leclercq, G, Laurent, G, Body, J-J
Publicado em 2004

Increased Dickkopf-1 expression in breast cancer bone metastases

Por Voorzanger-Rousselot, N, Goehrig, D, Journe, F, Doriath, V, Body, J J, Clézardin, P, Garnero, P
Publicado em 2007

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studie...

Por Body, J J, Diel, I J, Lichinitzer, M, Lazarev, A, Pecherstorfer, M, Bell, R, Tripathy, D, Bergstrom, B
Publicado em 2004

Loading and Skeletal Development and Maintenance

Por Bergmann, P., Body, J. J., Boonen, S., Boutsen, Y., Devogelaer, J. P., Goemaere, S., Kaufman, J., Reginster, J. Y., Rozenberg, S.
Publicado em 2010

Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club

Por Body, J.-J., Bergmann, P., Boonen, S., Boutsen, Y., Devogelaer, J.-P., Goemaere, S., Kaufman, J.-M., Rozenberg, S., Reginster, J.-Y.
Publicado em 2010

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications

Por Body, J.-J., Bergmann, P., Boonen, S., Devogelaer, J.-P., Gielen, E., Goemaere, S., Kaufman, J.-M., Rozenberg, S., Reginster, J.-Y.
Publicado em 2012

Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of t...

Por Bergmann, P, Body, J-J, Boonen, S, Boutsen, Y, Devogelaer, J-P, Goemaere, S, Kaufman, J-M, Reginster, J-Y, Gangji, V
Publicado em 2009

Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club

Por Body, J.-J., Bergmann, P., Boonen, S., Boutsen, Y., Bruyere, O., Devogelaer, J.-P., Goemaere, S., Hollevoet, N., Kaufman, J.-M., Milisen, K., Rozenberg, S., Reginster, J.-Y.
Publicado em 2011

Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club

Por Gielen, E., Bergmann, P., Bruyère, O., Cavalier, E., Delanaye, P., Goemaere, S., Kaufman, J.-M., Locquet, M., Reginster, J.-Y., Rozenberg, S., Vandenbroucke, A.-M., Body, J.-J.
Publicado no Calcif Tissue Int (2017)

Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.

Por Ralston, S. H., Thiébaud, D., Herrmann, Z., Steinhauer, E. U., Thürlimann, B., Walls, J., Lichinitser, M. R., Rizzoll, R., Hagberg, H., Huss, H. J., Tubiana-Hulin, M., Body, J. J.
Publicado em 1997

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases

Por Beuselinck, B, Wolter, P, Karadimou, A, Elaidi, R, Dumez, H, Rogiers, A, Van Cann, T, Willems, L, Body, J-J, Berkers, J, Van Poppel, H, Lerut, E, Debruyne, P, Paridaens, R, Schöffski, P
Publicado em 2012

Cancer-associated bone disease

Por Rizzoli, R., Body, J.-J., Brandi, M.-L., Cannata-Andia, J., Chappard, D., El Maghraoui, A., Glüer, C.C., Kendler, D., Napoli, N., Papaioannou, A., Pierroz, D.D., Rahme, M., Van Poznak, C.H., de Villiers, T.J., El Hajj Fuleihan, G.
Publicado no Osteoporos Int (2013)